Idiopathic pulmonary fibrosis epidemiology and demographics

Idiopathic pulmonary fibrosis Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Idiopathic pulmonary fibrosis from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
Diagnostic Study of Choice
History and Symptoms
Physical Examination
Laboratory Findings
Chest X Ray
CT
MRI
Other Imaging Findings
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Idiopathic pulmonary fibrosis epidemiology and demographics On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Idiopathic pulmonary fibrosis epidemiology and demographics All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Idiopathic pulmonary fibrosis epidemiology and demographics
CDC on Idiopathic pulmonary fibrosis epidemiology and demographics
Idiopathic pulmonary fibrosis epidemiology and demographics in the news
Blogs on Idiopathic pulmonary fibrosis epidemiology and demographics
Directions to Hospitals Treating Idiopathic pulmonary fibrosis
Risk calculators and risk factors for Idiopathic pulmonary fibrosis epidemiology and demographics

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Epidemiology and Demographics

Idiopathic Pulmonary Fibrosis is slightly more common in males and usually presents in patients greater than 50 years of age. Average survival from time of diagnosis varies between 2.5 and 3.5 years, depending on severity, although some patients live greater than 10 years.